Article Versions Notes

Ladel S, Schlossbauer P, Flamm J, Luksch H, Mizaikoff B, Schindowski K. Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650. Pharmaceutics. 2019; 11(8):367. https://doi.org/10.3390/pharmaceutics11080367

Ladel, Simone, Patrick Schlossbauer, Johannes Flamm, Harald Luksch, Boris Mizaikoff, and Katharina Schindowski. 2019. "Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650" Pharmaceutics 11, no. 8: 367. https://doi.org/10.3390/pharmaceutics11080367

Ladel, S., Schlossbauer, P., Flamm, J., Luksch, H., Mizaikoff, B., & Schindowski, K. (2019). Improved In Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650. Pharmaceutics, 11(8), 367. https://doi.org/10.3390/pharmaceutics11080367